The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna’s first chance to show the ...

There are two new COVID-19 variants circulating, posing a threat to a summer surge. Is your last vaccine dose still ...

Sales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter in a dramatic ...

More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of ...

Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.

Moderna shares fell in intraday trading Friday as it said the FDA has pushed back its RSV vaccine approval decision until the ...

There are calls for major COVID vaccine drugmakers to also withdraw their jabs after AstraZeneca withdrew its vaccine from ...

Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna's ...

The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.

AstraZeneca, which is withdrawing its COVID-19 vaccine, says independent estimates show that it saved over 6.5 million lives ...

The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7, 2024, the European ...

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled.